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Supplementary Appendixes A
through H are available online.doi:10.1016/j.jtcvs.2004.10.004Objective: We sought to determine the prevalence of outcomes and associated
patient and management factors for neonates with interrupted aortic arch.
Methods: From 1987 to 1997, a total of 472 neonates were enrolled prospectively
from 33 institutions. Competing risks methodology was used to determine simul-
taneous risk and associated incremental risk factors for death, initial and subsequent
left ventricular outflow tract procedures, and arch reinterventions.
Results: Overall survival was 59% at 16 years after study entry but improved with
successive birth cohort. In general, risk factors for death in each of the competing
risks analyses included lower birth weight, younger age at study entry, type B
interrupted aortic arch, and major associated cardiac anomalies. Of 453 patients who
had interrupted aortic arch repair, after 16 years 33% had died and 28% had
undergone an arch reintervention. Reintervention was more likely for those who had
truncus arteriosus repair, interrupted aortic arch repair by a method other than direct
anastomosis with patch augmentation, and the use of polytetrafluoroethylene as
either an interposition graft or a patch. From study entry, competing risks after 16
years showed that 28% had died and 34% had undergone an initial left ventricular
outflow tract procedure. Initial left ventricular outflow tract procedure was more
likely for those with single ventricle, type B interrupted aortic arch, bicuspid aortic
valve, or anomalous right subclavian artery. Among those who had undergone an
initial left ventricular outflow tract procedure, after 16 years 37% had died and 28%
had undergone a second procedure.
Conclusion: Anatomic features affect mortality and initial left ventricular outflow
tract procedures, whereas characteristics of the arch repair affect arch reintervention.
Interrupted aortic arch (IAA) occurs infrequently, and although most pa-tients have only an isolated ventricular septal defect (VSD), more complexassociated cardiovascular anomalies may occur. In addition, a spectrum ofleft ventricular outflow tract (LVOT) obstructive lesions, particularly sub-aortic stenosis, may further complicate management. Although recent re-ports have reflected improvements in operative survival, further interven-
tions are often required to address residual or recurrent left heart outflow or arch
repair obstructions. A previous Congenital Heart Surgeons Society (CHSS) study
reported outcomes for 183 neonates entered from 1987 to 1992.1 This report builds
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Don the previous report with a larger patient population,
longer duration of follow-up, and inclusion of patients with
major associated cardiac anomalies. It uses competing risks
methodology to identify the prevalence and factors associ-
ated with death, initial and subsequent procedures directed
toward actual and potential left heart outflow obstruction,
and residual or recurrent obstruction of the IAA repair.
Patients and Methods
Between January 1987 and December 1997, a total of 472 neonates
with IAA were admitted and enrolled by one of 33 CHSS member
institutions. The number of patients enrolled per institution ranged
from 1 to 57, with 15 institutions enrolling fewer than 10 patients
and 8 institutions enrolling more than 20 patients. Participation by
member institutions was voluntary and confidential, and ethical
approval was obtained according to local requirements. Ethics
approval for the CHSS Data Center is obtained annually from the
Research Ethics Board of the Hospital for Sick Children, Toronto.
Study Population
All patients with IAA admitted to a CHSS institution within 30
days of birth were eligible for inclusion. IAA was defined as either
a complete discontinuity or a nonpatent fibrous strand in the
transverse arch or aortic isthmus.
Data Collection
Data were abstracted from submitted copies of medical records
requested for initial and subsequent assessments, admissions, and
procedures and entered into a database by the Data Center staff and
some CHSS member surgeons. The most recent cross-sectional
follow-up was performed between March and June, 2003, with 186
deaths and follow-up completed for 139 (49%) of 286 presumed
survivors. However, if cross-sectional follow-up data from the
follow-up performed in 2002 are included for 28 children without
2003 follow-up, 167 (58%) had cross-sectional follow-up and the
vital status of 354 (75%) patients was known within 1 year of this
analysis.
Data Analysis
The goals of the analysis were to describe patient and management
characteristics and to relate these and institutions as incremental
risk factors in competing risks analysis of time-related mortality,
LVOT procedures, and IAA repair reinterventions. Data are given
as frequency, median with range, or mean  SD as appropriate,
with the number of nonmissing values indicated. All data analyses
were performed with SAS statistical software (version 8; SAS
Institute, Inc, Cary, NC). Multiphase parametric modeling of the
hazard function and competing risks methodology were used to
define rates of transition to mutually exclusive time-related events
and incremental risk-factors associated with each outcome, as
previously described.2 Additional information regarding statistical
techniques is given in Supplementary Appendix A.
Results
Patient Characteristics
Patient and morphologic characteristics are shown in Sup-
plementary Appendix B: Table 1.
344 The Journal of Thoracic and Cardiovascular Surgery ● FebrDeath With No Interventions
Nineteen patients had no completed procedures, and all of
these died at a median interval from admission of 11 days
(range 2-45 days). Causes of death included withdrawal of
support in 8 cases, cardiopulmonary arrest in 4, complica-
tions of prematurity in 4, and cardiac arrest during an
attempted procedure in 3. Independent factors from multiple
logistic regression analysis for an increased risk of death
with no completed interventions included lower and higher
birth weight (polynomial function, bootstrap reliability
57%) and need for dopamine infusion at presentation (reli-
ability 63%).
Overall Mortality
In total, 186 patients died. The hazard function for time-
related survival was characterized by a single early hazard
phase, with survival at 16 years of 59% (70% confidence
interval 56%-61%; Figure 1, A). Although a complete anal-
ysis of risk factors associated with overall mortality was not
performed, improving outcomes were evident for patients
born later in the study enrollment period (P  .001; Figure
1, B).
Interventions Before, With, and After IAA Repair
Only 5 patients had procedures performed before IAA re-
pair. Repair of IAA was performed in 453 patients at a
median age of 7 days (range 1-60 days). In 2 patients, IAA
repair occurred at the time of primary heart transplantation.
Characteristics of IAA repair are given in Supplementary
Appendix C: Table 2, and these variables were used in
multivariable analyses. A flow chart of the number of pa-
tients having initial and additional interventions aimed at
potential or actual LVOT obstruction, reinterventions for
residual or recurrent arch obstruction, and subsequent mor-
tality is given in Supplementary Appendix D: Electronic
Figure 1.
Competing Risks for Intervention for Arch Repair
Obstruction
Among the 453 patients who underwent repair of IAA, this
was followed by death in 143 cases and survival to a
reintervention for IAA repair obstruction in 109 cases. Of
the 109 arch reinterventions, 52 were by transcatheter bal-
loon dilation and 57 were surgical. The time-related hazard
function for survival to an IAA repair intervention showed
two phases, an early phase accounting for 89 events and a
smaller constant hazard phase accounting for 20 events. The
time-related hazard function for death without an IAA re-
pair intervention was characterized by an early phase only.
The competing risks for the two events showed that 16 years
after IAA repair, 33% had died without an IAA repair
intervention, 29% were surviving to an IAA repair inter-
vention, and 38% remained alive without an IAA repair
intervention (Figure 2). Incremental risk factors from mul-
uary 2005
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and exclusive of institutions, are given in Supplementary
Appendix E: Table 3.
To determine the impact of type of arch repair on sub-
sequent outcomes, the multivariable competing risk model
was then solved for various combinations of characteristics.
Patient variables were set to mean values, except for type B
IAA with no associated anomalies. Prediction for such a
patient had repair been accomplished with a direct anasto-
mosis with patch augmentation showed that at 16 years after
repair, there was a 23% chance of survival to arch reinter-
vention, an 18% chance of death, and a 59% chance of
survival without reintervention. For repair by direct anasto-
mosis without patch augmentation, at 16 years, there was a
24% chance of survival to arch reintervention, an increased
chance of death at 30%, and a chance of survival without
reintervention of 47%. For repair accomplished by place-
ment of a polytetrafluoroethylene (PTFE) interposition graft
with no arch augmentation, at 16 years, there was a 54%
chance of survival to arch reintervention, a 30% chance of
death, and a 16% chance of survival without reintervention.
Competing Risks for Initial Intervention for LVOT
Obstruction
From admission to a CHSS institution, an initial interven-
tion aimed at dealing with potential or actual LVOT ob-
struction was performed in 143 patients, with another 128
patients dying without such an intervention. The initial
Figure 1. Overall time-related survival of 472 neonates
CHSS member institution. Solid lines represent parame
intervals (CI); circles with error bars represent nonpar
survival for first 5 years after admission stratified by pintervention was performed at the time of IAA repair for 91
The Journal of Thoracipatients. The types of interventions are given in Supplemen-
tary Appendix F: Table 4, together with the number of
patients who underwent a subsequent additional LVOT
Figure 2. Competing risks analysis for subsequent intervention
for residual or recurrent obstruction at IAA repair site. All pa-
tients began at time of repair of IAA (n 453) and could transition
to either death or subsequent intervention for residual or recur-
rent obstruction at arch repair site. Solid lines represent para-
metric point estimates; dashed lines enclose 70% confidence
intervals; circles with error bars represent nonparametric esti-
mates. Proportion of patients (expressed as percentage of total)
in each of 3 categories at any given time after IAA repair.
IAA. All patients began at time of initial admission to
point estimates; dashed lines enclose 70% confidence
ric estimates. A, Overall survival. B, Predicted overall
t date of birth.with
tric
ametintervention or who died without further LVOT interven-
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Dtion. The hazard function for time-related transition to an
initial LVOT intervention was characterized by a steep early
hazard phase (90 early phase-events) and a prolonged de-
creasing late hazard phase (53 late-phase events). The haz-
ard function for transition to death without an initial LVOT
intervention was characterized by a steep early hazard phase
only. The competing risks for the two events showed that after
16 years from admission, 28% had died and 38% were sur-
viving without an LVOT intervention, with 34% surviving to
an initial LVOT intervention (Figure 3). Incremental risk fac-
tors from multivariable hazard modeling of each outcome, both
exclusive and inclusive of institutions, are given in Supple-
mentary Appendix G: Table 5. For death without an initial
LVOT intervention, the relationships with date of birth, birth,
weight and age at admission were complex.
To determine the impact of major anatomic risk factors
on freedom from initial LVOT procedure or death, the
multivariable competing risk model was then solved for
various combinations of characteristics. Patient variables,
except for the anomalies of interest, were set to mean
values. Prediction for a patient with isolated type B IAA
with an anomalous right subclavian artery showed that at 16
years after admission, there was a 30% chance of survival to
an initial LVOT procedure, a 27% chance of death, and a
43% chance of survival without an LVOT procedure. In
contrast, for a patient with single ventricle, at 16 years, there
was a 91% chance of survival to an initial LVOT procedure
(usually creation of a main pulmonary artery–aorta connec-
Figure 3. Competing risks analysis for initial procedure aimed at
addressing potential or actual LVOT obstruction. All patients
began at time of initial admission to CHSS member institution (n
 472) and could transition to either death or initial procedure
aimed at addressing potential or actual LVOT obstruction. Solid
lines represent parametric point estimates; dashed lines enclose
70% confidence intervals; circles with error bars represent non-
parametric estimates. Proportion of patients (expressed as per-
centage of total) in each of 3 categories at any given time after
IAA repair.tion, although 3 patients had some sort of subaortic resec-
346 The Journal of Thoracic and Cardiovascular Surgery ● Febrtion), a 9% chance of death, and almost no chance of
survival without an LVOT procedure. For a patient with
associated truncus arteriosus, at 16 years, there was an 18%
chance of survival to an initial LVOT, a 56% chance of
death, and a 26% chance of survival without an LVOT
procedure.
Competing Risks for Subsequent Intervention for
Recurrent or Residual LVOT Obstruction After Initial
Intervention
Of the 143 patients who underwent an initial intervention,
28 survived to an additional LVOT intervention, most com-
monly a Konno procedure, and 53 died without subsequent
intervention. The hazard function for time-related transition
to a subsequent LVOT intervention was characterized by
prolonged and gradually declining late hazard phase only.
The hazard function for death without a subsequent LVOT
intervention was characterized by a steep early phase only.
The competing risks for the two events showed that after 16
years from initial LVOT intervention, 37% had died, 35%
were surviving without a subsequent LVOT intervention,
and 28% survived to a subsequent LVOT intervention (Fig-
ure 4). Incremental risk factors from multivariable hazard
modeling of each outcome, both inclusive and exclusive of
institutions, are given in Supplementary Appendix H: Table
6.
To determine the impact of type of initial LVOT proce-
Figure 4. Competing risks analysis for subsequent procedure
aimed at addressing residual or recurrent LVOT obstruction. All
patients began at time of initial procedure aimed at addressing
potential or actual LVOT obstruction (n  143) and could transi-
tion to either death or similar subsequent procedure. Solid lines
represent parametric point estimates; dashed lines enclose 70%
confidence intervals; circles with error bars represent nonpara-
metric estimates. Proportion of patients (expressed as percent-
age of total) in each of 3 categories at any given time after IAA
repair.dure as a risk factor for freedom from a second LVOT
uary 2005
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was then solved for various combinations of characteristics.
Patient variables, except for procedural variables, were set
to mean values. Prediction for a patient whose initial LVOT
procedure was balloon dilation of the LVOT showed that at
16 years after the initial procedure, there was an 84%
chance of survival to a second LVOT procedure, a 16%
chance of death, and almost no chance of survival without
a second procedure. For a patient with an initial Norwood
procedure, there was a 17% chance of survival to a second
LVOT procedure (2 patients with favorable anatomy sur-
vived to undergo a subsequent conal resection and biven-
tricular repair), a 50% chance of death, and a 33% chance of
survival without a second procedure.
Predicted Outcomes for a Realistic Patient With an
Optimal Risk Factor Profile
Given the complexity of patient characteristics and manage-
ment, the multivariable competing risks analyses were
solved to predict what the outcomes might be for a realistic
patient with an optimal risk factor profile, to determine what
might be achieved if all risk factors could be neutralized.
This patient was defined as a male born in 1997 with a birth
weight of 3.5 kg who was admitted to a non–high-risk
CHSS member institution at 4 days after birth. This patient
would have a single, large, malaligned VSD closed at the
time of IAA repair, which was achieved with a direct
anastomosis with a non-PTFE patch augmentation, and no
associated anomalies. Prediction for arch reintervention
would show that at 16 years after repair, he would have a
24% chance of survival to reintervention, a 7% chance of
death, and a 69% chance of survival without reintervention.
Prediction for an initial LVOT procedure would show that
at 16 years after admission, he would have a 16% chance of
surviving to an LVOT procedure, a 5% chance of death, and
a 79% chance of survival without a procedure. If he did
undergo an initial LVOT procedure, he would be predicted
after 16 years to have a 29% chance of survival to a second
procedure, a 6% chance of death, and a 65% chance of
survival without a second procedure.
Discussion
Overall Mortality
Although overall mortality was high, there was a significant
and important improvement with time in our series. The
previous CHSS report noted survival at 4 years after IAA
repair of 63%, although the analysis was limited to those
patients with associated VSD.1 Risk factors for time-related
death included lower birth weight, younger age at repair,
type B IAA, outlet and trabecular VSD locations, smaller
size of the VSD, and the presence of subaortic narrowing,
together with some individual institutions. Procedural risk
factors included failure to address LVOT obstruction at the
time of repair, a Damus-Kaye-Stansel procedure, and use of
The Journal of Thoracisubaortic myectomy or myotomy to address subaortic nar-
rowing.
There have been many case reports but few case series
reporting outcomes of IAA. An early report by Sell and
colleagues3 of 63 patients operated on from 1974 to 1987
showed an overall survival of 47% at 10 years. Fulton and
coworkers4 reported an overall survival of 85% at 12 years
after IAA repair in 72 patients operated on from 1985 to
1997, with the only significant risk factor for death being a
longer duration of cardiopulmonary bypass. Serraf and col-
leagues5 studied 82 patients seen from 1985 to 1995 and
reported an overall survival of 70% at 5 years, with similar
survivals for those with simple and complex lesions but
decreased survival for those with subaortic obstruction.
Survival did not differ between single- and 2-stage repairs.
Schreiber and associates6 reported an overall survival of
67% at 10 years after repair for 94 patients operated on from
1975 to 1999, with LVOT obstruction and a 2-stage ap-
proach significant risk factors for early mortality. Tlaskal
and coworkers7 studied 40 patients who underwent proce-
dures from 1977 to 1997, with 50% dying within 30 days of
surgery. Risk factors for early mortality included preoper-
ative complications, acidosis, poor clinical condition, and
earlier year of surgery, with better survival for those under-
going primary repair rather than palliation. Similar to our
series, others have also reported a small proportion of pa-
tients who either died or had support withdrawn and did not
undergo repair.
In our competing risks analysis, several variables were
consistently associated with an increased mortality; these
included truncus arteriosus, IAA type B or C, younger age
at study entry, lower birth weight, and female sex. For death
after an initial LVOT procedure or after IAA repair, the
procedural characteristics were also predictive. Although
some early reports favored a staged approach,8-10 the sub-
sequent trend has been toward primary repair11-13 with
selective use of the staged approach.7 Death after an initial
procedure for LVOT obstruction was more likely if the
procedure included pulmonary artery band or shunt place-
ment or a Norwood procedure, indicating the elements of
staged repairs associated with increased mortality. Death
after IAA repair was also predicted by some procedural
factors, including creation of a Damus-Kaye-Stansel shunt
and not augmenting the arch repair. This would suggest that
more severe LVOT obstruction requiring bypass procedures
and possibly failure to relieve arch obstruction contribute to
mortality. Features and management of the VSD were ad-
ditional significant risk factors for mortality. Absence of
malalignment of the VSD, small size of the VSD, and the
presence of multiple VSDs predicted death; these may be a
marker for the presence of associated complex cardiac
anomalies, whereas malalignment is known to be a mech-
c and Cardiovascular Surgery ● Volume 129, Number 2 347
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lesions.
Method of IAA Repair and Subsequent Arch
Procedures
Factors significantly associated with an increased risk of
intervention for residual or recurrent arch obstruction in-
cluded younger and older age at study entry, associated
aortopulmonary window or double-outlet right ventricle,
two particular institutions, and institutions contributing
fewer than 10 patients, all of which were associated with
early reintervention. In addition, procedural risk factors
influenced late reinterventions, including repair of truncus
arteriosus, use of PTFE material in the arch repair (all
interposition grafts and 6 of the patch augmentations), and
repair of the arch by a method other than direct anastomosis
with patch augmentation. Obstruction of the arch repair has
not been optimally studied, and reports are largely descrip-
tive. Fulton and coworkers4 noted a freedom from reinter-
vention for arch obstruction of 83% at 12 years after repair.
Sell and colleagues3 reported that 47% of early survivors,
more commonly those with a direct anastomosis, had arch
obstruction develop. Serraf and colleagues5 noted recurrent
arch obstruction in 27%, with no relation to the type of
initial arch repair. The management of arch obstruction
depends on the type of initial repair. Interposition grafts and
bypass conduits require surgical management, whereas
anastomotic narrowings can be effectively addressed by
transcatheter balloon dilatation, albeit with a risk of subse-
quent recurrence.14 Our data would suggest that where
possible the preferred method of arch repair is by direct
anastomosis augmented with either homograft or pericardial
material, giving the best survival free of reintervention.
LVOT Obstruction
LVOT obstruction can occur from subaortic narrowing,
aortic valve hypoplasia or stenosis, and ascending aorta
hypoplasia, and it can greatly complicate patient manage-
ment. We noted that patients who underwent initial LVOT
procedures had lower birth weight, type B IAA, single
ventricle, bicuspid aortic valve, or anomalous right subcla-
vian artery. Similar to our series, both Fulton and cowork-
ers4 and Geva and associates15 noted that the presence of
type B IAA and anomalous right subclavian artery were risk
factors for LVOT obstruction, presumably because of alter-
ations in blood flow across the LVOT. Of note, two insti-
tutions were associated with a greater likelihood of an initial
LVOT procedure. Fulton and coworkers4 also noted that the
presence of LVOT obstruction did not influence overall
survival and that most did not require an intervention. Serraf
and colleagues5 documented catch-up growth of the LVOT.
However, we noted that among 143 patients who underwent
an initial LVOT procedure, 52 procedures were as addi-
tional operations after IAA repair. Nonetheless, some pa-
348 The Journal of Thoracic and Cardiovascular Surgery ● Febrtients who require an initial LVOT bypass procedure can go
on to have biventricular repair.16
The heterogeneity of LVOT obstructions mandates indi-
vidual management.17,18 Clearly, for some patients the de-
cision of when and how to intervene is difficult. Salem and
colleagues19 performed a detailed review of echocardio-
graphic measurements, and showed that an absolute diam-
eter of the aortic valve annulus less than 4.5 mm and a Z
score less than5 completely predicted the development of
LVOT obstruction after arch repair, whereas size of the
subaortic region did not.19 Likewise, catch-up growth of the
aortic valve annulus was demonstrated. In contrast, Apfel
and coworkers20 showed that echocardiographic measure-
ments of the subaortic region predicted LVOT obstruction.
Geva and associates15 found an indexed cross-sectional area
of the LVOT less than 0.7 mm/m2 but not aortic valve
dimensions to predict LVOT obstruction. Careful quantita-
tive echocardiographic assessment of the LVOT structures
can assist decision making. Unfortunately, these data were
not available in our study.
Unlike previous reports, we identified factors associated
with a subsequent LVOT intervention after an initial pro-
cedure. Because of the heterogeneity of obstruction and the
methods by which it can be addressed, only absence of a
large VSD, initial transcatheter balloon dilation of the
LVOT, and one institution (protective) were significantly
associated with a second LVOT procedure. Although bal-
loon dilatation can be an effective method of addressing
isolated aortic valve stenosis, it is inadequate to address
aortic valve hypoplasia and subaortic obstruction, which are
more likely in the setting of IAA.
Summary
Management of IAA remains complex, although overall
mortality appears to be improving. Patients with low birth
weight, immediate presentation, type B IAA, and major
associated cardiac anomalies remain at high risk for death
and initial LVOT procedures. Although this issue was not
addressed in our study, predictors of which patients will
require LVOT procedures for potential or actual obstruction
are difficult to identify except in specific circumstances
because of the wide spectrum of mechanisms, severity, and
natural history. If the initial procedure required is an LVOT
bypass procedure, this marks a subgroup at high-risk for
death, with more complex subsequent management. For
patients who undergo balloon dilatation of the LVOT, there
is a high risk of residual or recurrent obstruction requiring
additional procedures. The optimal method of repair of IAA
appears to be with direct anastomosis with non-PTFE patch
augmentation, which reduces subsequent mortality but has a
minimal impact on reducing need for reintervention. The
use of an interposition graft appears to necessitate late-
phase reintervention in survivors. Even if the risk factors
uary 2005
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Didentified in this study can be neutralized, approximately a
7% mortality will probably remain, largely occurring early;
although this was seen at the end of the era studied, which
may not completely reflect contemporary results.
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Discussion
Dr Ralph S. Mosca (New York, NY). IAA is a relatively rare,
morphologically heterogeneous lesion with complexities that can
be overlooked in its simplistic name. Today’s excellent presenta-
tion builds on a previous study, also from the members of the
CHSS. The first study confirmed the utility of a single-stage
approach. The importance of multiple levels of obstruction in the
left heart complex was stressed, but subaortic myomectomy and a
Damus-Kaye-Stansel procedure were both risk factors for death.
As shown again today, reoperative procedures were common and
yielded variable results.
This morning’s analysis used competing risk methodology to
determine simultaneous risk and associated incremental risk for
death and reintervention. McCrindle and coworkers have made it
clear that anatomic features affect mortality and the need for
LVOT interventions, whereas the type of arch repair determines
the need for reintervention on the arch. This is an elegant analysis,
but it falls short, I believe, of answering some key questions
pertaining to the need for additional and subsequent reintervention.
This is not a criticism of the statistical technique; rather, perhaps
it reflects a lack of important preoperative data.
For example, a number of patients died from what appears to be
inadequate LVOTs, both with and without intervention. Dr Mc-
Crindle, your analysis suggests that patients with more severe
LVOT obstruction were at additional risk for mortality. Much of
the discussion concerning the care of this lesion concerns the need
for an optimal method of relieving the subaortic obstruction. Were
there no data available to try to relate the size and structure of the
subaortic LVOTs to initial intervention and subsequent outcomes,
and can we expect that in the future updates?
Dr McCrindle. First of all, with the original article from the
CHSS, there were some limited data available for some of the
measurements of different LVOT structures. However, that data
collection ended at a certain point, an analysis was performed, and
then the study was reactivated. The subsequent data collection
didn’t focus on collecting these kinds of variables. The answer
would likely require a detailed and quantitative analysis of initial
echocardiograms. We previously published a study of patients with
critical aortic stenosis in which we were able to obtain the initial
echocardiogram for a lot of those patients. Logistically, however,
this type of data collection, from an institutional research ethics
review board standpoint, is becoming more and more problematic
and more and more difficult to do. Part of the challenge relates to
interpretation and compliance with the new Health Insurance Port-
ability and Accountability Act guidelines, which restrict and reg-
ulate access to that type of data.
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DHowever, if you examine the literature regarding studies of
IAA that have incorporated some of those echocardiographic mea-
surements, there appears to be no real consistency regarding which
structures, measurements, and cut points most optimally predict
whether someone has LVOT obstruction that needs to be ad-
dressed at the time of an arch repair.
Dr Mosca. I agree. That is why I was hoping we would have
seen it here, but I understand your concerns.
The association of truncus arteriosus with IAA was a risk factor
for both reintervention and death. Truncus obviously brings along
its own intricacies but is usually free of LVOT obstruction. What
is it about the association of truncus with IAA that makes it
particularly pernicious to deal with?
Dr McCrindle. I think the method of actually repairing the
interruption at the same time as dealing with the truncus is much
more complex than dealing with either lesion in isolation and
probably contributes to longer procedure times, which may influ-
ence subsequent outcomes. Also, the complexity of configuring the
arch in the presence of truncus is much more complex, with many
more sites at which things can go wrong and predispose toward
subsequent reinterventions and obstructions.
Dr Mosca. It was interesting that a large VSD was protective
from the need for reintervention on the LVOT. What are your
thoughts concerning this observation?
Dr McCrindle. I would suspect that the presence of a small
VSD and also probably the presence of VSDs that were not
malaligned suggests a different disease process, and probably
those patients were more likely to have associated cardiac anom-
alies that would have influenced the outcomes as well.
Dr Mosca. Thank you very much. I enjoyed your presentation.
Dr John E. Foker (Minneapolis, Minn). My congratulations on
an excellent presentation. Although I am reluctant to advocate a
retro approach, at our institution staged procedures seem to offer
some advantage, particularly for the sicker infants. We have had
36 such cases without a surgical death, all done without bypass and
without interruption of the cerebral circulation.
The really interesting thing, though, is that despite the theoretic
objections to pulmonary arterial banding and conal-truncal mal-
alignment, we have not had LVOT tract obstruction develop in any
children after this procedure. We have had 2 who had it at birth,
but none have had it develop. Of course, you do need to replace or
augment the arch at about 12 years of age. Have you looked at the
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that LVOT obstruction would develop?
Dr McCrindle. We did not particularly look at the timing as a
risk factor for when the LVOT procedure was performed in rela-
tionship to the repair. I can state that 91 of the 143 patients who
underwent a LVOT procedure had it performed at the time of the
arch repair, but in the analysis that didn’t fall out as a specific risk
factor for outcomes. Given that our previous analysis focused on
staging, however, this was not a focus of the current study, which
emphasized interventions for LVOT obstruction and arch repair
obstruction.
Dr Ross Ungerleider (Portland, Ore). You and your col-
leagues at the CHSS data center should be congratulated on the
tireless work that you do to help us understand these complex
patients. My questions are really quite simple.
First, could you tell us a little bit about the influence of
DiGeorge syndrome on the outcome for patients with IAA and
associated defects?
Dr McCrindle. DiGeorge syndrome was only present in about
a quarter of the patients for which that datum was reported, but
clearly for the era during which these patients were initially
entered, the whole concept of DiGeorge and testing weren’t well
established. I would suspect the incidence of DiGeorge syndrome
to be much higher than what we were able to report. What we are
finding in our annual follow-up of survivors is that in some cases
the diagnosis is being made late. Nonetheless, among those pa-
tients for whom it was documented that they had DiGeorge, it was
not an incremental risk factor, particularly for mortality.
Dr Ungerleider. Second, as the periods evolved, did you notice
a change in the way the LVOT problems were addressed? Were
there more successes moving away from some of the older proce-
dures to Ross-Konno type reconstructions of the LVOTs, or did
you notice that there were different procedures for the arches that
were becoming more successful in the later years?
Dr McCrindle. In general, we didn’t really look for trends with
time in the types of procedures that were performed, but we did
look for trends with time in the outcomes that occurred. My
impression of the data would be that the procedures to address
LVOT obstruction were complex throughout the entire study pe-
riod, with many novel variations for cases in which simple resec-
tions were not deemed sufficient or feasible.
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Appendix A. Statistical Methods
Flow charts were created to track patients though multiple con-
secutive procedures and deaths. Competing risks analyses were
used to examine rates of transition from an initial state (hazard
function) to the mutually exclusive time-related events of various
procedures and death without that procedure. This was used to
determine to proportion of patients reaching these events or states
at any given time after the initial state.
Noninformative imputation based on available data was used to
calculate and place the mean for missing values. Relevant missing
value indicator variables were created and included in multivariable
analyses to adjust for possible bias introduced by missing data.
Competing risks analyses were performed in a similar manner
for each of the following: (1) from initial admission to a CHSS
member institution to either death or an initial procedure aimed at
addressing potential or actual LVOT obstruction, (2) from an
initial procedure aimed at addressing potential or actual LVOT
obstruction to either death or a subsequent similar procedure, and
(3) from IAA repair to either death or a subsequent intervention for
residual or recurrent obstruction at the arch repair site.
For each competing risks analysis, non–risk-adjusted nonpara-
metric estimates for time-related freedom from death or the spec-
ified procedure were plotted with the Kaplan-Meier method. The
underlying hazard function was modeled parametrically, searching
for multiple phases of risk, as previously described.2 Demo-
graphic, morphologic, and procedural factors associated with each
outcome were sought through multivariable analysis of these para-
metric models. Only variables associated with more than 5 events
were included, to minimize the risk of model overdetermination.
For continuous variables, various mathematic transformations
were tested for optimal calibration of the relationship to risk, and
the significance of various interaction terms were explored. Boot-
strap bagging with cluster analysis was used to guide final variable
selection and to assess reliability of variable inclusion into final
multivariable models. Missing value indicator variables were en-
tered into final multivariable models as appropriate. The multiva-
riable models were solved in competing risks format for multiple
combinations of risk factors to explore the magnitude of effect of
these factors and to predict outcomes for patients with given
characteristics.
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Supplementary Appendix B: TABLE 1. Patient characteristics (n  472)
Variable No. Missing Value Deaths (n  186)
Demographic characteristics
Age at admission (d, median and range) 468 4 3 (birth-30)
Demographic characteristics
Age at admission (d, median and range) 468 4 3 (birth-30)
Birth weight (kg, mean  SD) 190 282 3.04  0.64
Sex (female/male) 471 1 234:237 80:106
Noncardiac anomaly (No.) 472 0 165 (35%) 68 (41%)
DiGeorge syndrome (No.) 472 0 86 (18%) 33 (38%)
Morphologic characteristics (No.)
Type of IAA
Type A 468 0 130 (28%) 33 (26%)
Type B 468 0 331 (70%) 144 (44%)
Type C 468 0 7 (1%) 7 (100%)
Major associated cardiac anomalies
None—isolated VSD 472 0 341 (72%) 121 (35%)
None—intact ventricular septum 472 0 7 (1%) 2 (29%)
Aortopulmonary window 472 0 20 (4%) 3 (15%)
Complete atrioventricular septal defect 472 0 3 (1%) 3 (100%)
Atrioventricular discordance 472 0 2 (1%) 1 (50%)
Double-outlet right ventricle 472 0 8 (2%) 4 (50%)
Partial anomalous pulmonary venous return 472 0 1 (1%) 1 (100%)
Single ventricle 472 0 13 (3%) 9 (69%)
Transposition of great arteries with VSD 472 0 26 (6%) 9 (35%)
Truncus arteriosus 472 0 51 (11%) 34 (67%)
Bicuspid aortic valve 229 243 149 (65%) 57 (38%)
Anomalous right subclavian artery 427 45 108 (25%) 45 (42%)
Left superior vena cava 440 32 35 (8%) 19 (54%)
Large patent ductus arteriosus 281 191 251 (89%) 94 (37%)
Large VSD 392 80 322 (82%) 123 (38%)
Multiple VSDs 383 89 31 (8%) 14 (45%)
Malalignment of VSD 472 0 165 (35%) 74 (32%)
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Supplementary Appendix C: TABLE 2. Characteristics of IAA repair (n  453)
Variable No. Missing Value
Age at repair (d, median and range) 452 1 7 (1-60)
Weight at repair (kg, mean  SD) 365 88 3.09  0.59
Concomitant procedures (No.)
Closure of VSD 453 0 270 (60%)
Pulmonary artery banding 441 12 96 (22%)
Main pulmonary artery–aorta anastomosis 453 0 50 (11%)
Repair of truncus arteriosus 453 0 42 (9%)
Systemic–pulmonary artery shunt placement 453 0 34 (8%)
Mitral valve repair 450 3 1 (1%)
Technique of arch repair (No.)
Approach
Median sternotomy 453 0 328 (72%)
Thoracotomy 453 0 123 (27%)
Both sternotomy and thoracotomy 453 0 2 (1%)
Augmentation of aortic arch 453 0 115 (25%)
Type of repair of IAA
Direct anastomosis with no patching 453 0 267 (59%)
Direct anastomosis with patching 453 0 125 (28%)
Interposition graft 453 0 59 (13%)
Main pulmonary artery–aorta bypass conduit 453 0 2 (1%)
Use of graft material 453 0 187 (41%)
PTFE 58
Pulmonary artery homograft 52
Other 28
Pericardium 23
Aortic homograft 19
Xenograft 4
Unspecified homograft 3
Subclavian artery
None divided 453 0 385 (85%)
Left divided 453 0 39 (9%)
Right divided 453 0 23 (5%)
Both divided 453 0 6 (1%)
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Appendix D: Electronic Figure 1. Flow chart illustrating procedures for IAA repair, LVOT obstruction, and
IAA repair reintervention and associated deaths for 472 neonates with IAA.
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Supplementary Appendix E: TABLE 3. Incremental risk factors for time-related transition from IAA repair
(n  453) to either a reintervention at the IAA repair site or death, with and without institutions as
additional risk factors
Variable
Parameter
estimate  SE
P
value
Reliability
(%)
For subsequent IAA reintervention
Without institutions
Early phase
Younger and older age at admission* See legend 65%
Aortopulmonary window 1.11 0.35 .001 75%
Double-outlet right ventricle 1.40 0.53 .007 60%
Late phase
Repair of associated truncus arteriosus at IAA repair 2.95 0.65 .001 49%
Repair of IAA by method other than direct anastomosis
with patch augmentation
1.61 0.94 .09 56%
Use of PTFE for IAA repair 2.60 0.56 .001 58%
With institutions
Early phase
Younger and older age at admission* See legend 78%
Aortopulmonary window 0.95 0.36 .009 61%
Double-outlet right ventricle 1.55 0.53 .004 61%
Institution E 1.52 0.42 .001 82%
Institution F 1.42 0.42 .001 52%
Institutions contributing 10 patients 0.74 0.26 .005 80%
Late phase
Repair of associated truncus arteriosus at IAA repair 2.43 0.72 .001 49%
Use of PTFE for IAA repair 2.57 0.61 .001 52%
For death without IAA reintervention
Without institutions
Early phase only
Earlier date of birth† 0.008 0.003 .008 88%
Lower weight at IAA repair‡ 4.20 0.89 .001 68%
Truncus arteriosus 0.81 0.23 .001 82%
IAA type B or C 0.84 0.24 .001 68%
VSD size not large 0.56 0.22 .01 76%
Absence of malalignment of the VSD 0.51 0.19 .007 57%
No augmentation of aortic arch at IAA repair 0.66 0.22 .002 56%
Main pulmonary artery–aorta anastomosis performed at
IAA repair
0.81 0.24 .001 56%
With institutions
Earlier date of birth† 0.007 0.003 .03 87%
Lower weight at IAA repair§ 2.19 0.40 .001 95%
Truncus arteriosus 0.90 0.23 .001 73%
IAA type B or C 0.66 0.24 .006 50%
VSD size not large 0.64 0.22 .004 71%
Multiple VSDs 0.65 0.32 .04 50%
No augmentation of aortic arch at IAA repair 0.60 0.22 .008 58%
Main pulmonary artery–aorta anastomosis performed at
IAA repair
0.92 0.23 .001 66%
Institution A 0.63 0.27 .02 46%
Institution C 1.14 0.27 .001 95%
Institution G (protective) 0.68 0.31 .03 77%
*Complex polynomial function including two terms, age at admission in days and the logarithm of age at admission. †After squared transformation of the
interval from study onset to patient date of birth in years. ‡After inverse transformation of weight at IAA repair in kilograms. §After logarithmic
transformation of weight at IAA repair in kilograms.
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Supplementary Appendix F: TABLE 4. Type of initial intervention aimed at potential or actual LVOT
obstruction (n  143)
Initial LVOT intervention No. Died
Subsequent
LVOT
intervention
Primary cardiac transplantation 2 1 0
Aortic valve intervention
Transcatheter balloon valvotomy/dilatation of subaortic stenosis 10 0 8
Surgical valvuloplasty 3 1 0
Surgical valvotomy 1 0 0
Aortic valve replacement 1 1 0
Transcatheter balloon valvotomy/dilatation of subaortic stenosis 10 0 8
Subaortic surgical intervention
Resection of LVOT obstruction 40 8 10
Conal resection 20 8 4
Enlargement of VSD 6 3 0
Conal resection with VSD enlargement 3 1 1
Konno procedure with aortic valve replacement 5 0 2
Modified Konno procedure 1 0 1
LVOT obstruction bypass intervention
Transection of MPA with side-to-side anastomosis to ascending aorta 35 21 2
Transection of MPA with end-to-side anastomosis to ascending aorta 6 2 0
End-to-end anastomosis of MPA to descending aorta with PA banding 4 2 0
Creation of an MPA to ascending aorta window with PA banding 4 3 0
Conduit placement from MPA to descending aorta with PA banding 1 1 0
Left ventricle–descending aorta conduit placement 1 1 0
MPA, Main pulmonary artery; PA, pulmonary artery.
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Supplementary Appendix G: TABLE 5. Incremental risk factors for time-related transition from admission
(n  472) to either an initial LVOT intervention or death, with and without institutions as additional risk
factors
Variable
Parameter
estimate  SE P value
Reliability
(%)
For initial LVOT intervention
Without institutions
Early phase
Lower birth weight* 3.98 1.52 .009 45%
Single ventricle 1.66 0.48 .001 84%
IAA type B 0.85 0.30 .004 63%
Late phase
Single ventricle 3.12 0.84 .001 33%
Anomalous right subclavian artery 0.74 0.35 .04 50%
Bicuspid aortic valve 1.32 0.70 .06 55%
With institutions
Early phase
Lower birth weight* 2.70 1.57 .09 55%
Single ventricle 1.62 0.50 .001 82%
IAA type B 0.82 0.30 .006 66%
Institution A 0.94 0.34 .005 42%
Institution B 0.96 0.32 .002 46%
Late phase
Single ventricle 3.14 0.79 .001 33%
Anomalous right subclavian artery 0.77 0.34 .04 55%
Bicuspid aortic valve 1.31 0.68 .06 46%
For death without initial LVOT intervention
Without institutions
Early phase only
Earlier date of birth† See legend 98%
Lower birth weight‡ See legend 97%
Female sex 0.39 0.18 .04 53%
Younger age at admission§ 0.26 0.11 .02 64%
Truncus arteriosus 1.05 0.21 .001 94%
IAA type B or C 0.58 0.24 .02 81%
With institutions
Earlier date of birth See legend 97%
Lower birth weight‡ See legend 98%
Female sex 0.45 0.19 .02 36%
Younger age at admission§ 0.26 0.11 .02 64%
Truncus arteriosus 1.06 0.21 .001 58%
IAA type B or C 0.52 0.24 .03 48%
Institution C 0.89 0.29 .003 58%
Institution D 1.19 0.48 .02 50%
*After inverse transformation of the square of birth weight. †Complex polynomial function including two terms, interval from study onset to patient date
of birth in years and the inverse transformation of this interval. ‡Complex polynomial function including two terms, the logarithmic transformation and the
inverse transformation of birth weight in kilograms. §After logarithmic transformation. Complex polynomial function including two terms, interval from study
onset to patient date of birth in years after squared transformation and additionally after inverse transformation of the squared transformation.
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Supplementary Appendix H: TABLE 6. Incremental risk factors for time-related transition from an initial
LVOT intervention (n  143) to either a subsequent LVOT intervention or death, with and without institutions
as additional risk factors
Variable
Parameter
estimate  SE P value
Reliability
(%)
For subsequent LVOT intervention
Without institutions
Late phase only
Initial balloon dilatation of subaortic obstruction .63  0.42 0.001 54%
VSD size not large 0.87  0.41 0.04 63%
With institutions
Initial balloon dilation of subaortic obstruction 2.63  0.53 0.001 54%
VSD size not large 1.20  0.44 0.006 70%
Institution G (protective) 1.68  0.64 0.009 57%
For death without subsequent LVOT intervention*
Early phase only
Earlier date of birth† 0.19  0.06 0.001 71%
Female sex 0.61  0.29 0.04 51%
Absence of malalignment of VSD 1.29  0.35 0.001 76%
Systemic-pulmonary artery shunt with initial LVOT intervention 1.74  0.63 0.006 49%
Pulmonary artery band with initial LVOT intervention 2.01  0.56 0.001 51%
Closure of VSD with initial LVOT intervention 2.29  0.66 0.001 54%
Lower patient weight at initial LVOT intervention‡ 6.75  1.41 0.001 81%
Initial LVOT procedure of main pulmonary artery–aorta anastomosis
with either systemic-pulmonary artery shunt or right ventricle–
pulmonary artery conduit (interaction term)
0.87  0.40 0.03 70%
*No institutions were significant incremental risk factors. †Defined as interval in years from January 1, 1987, to patient’s date of birth. ‡After inverse
transformation of weight in kilograms.
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